[Polysaccharides from Scurrula parasitica L. inhibit sarcoma S180 growth in mice].

Zhongguo Zhong Yao Za Zhi

College of Life Sciences, Fujian Normal University, Fuzhou 350108, China.

Published: February 2010

To study the anti-tumor activity of Scurrula parasitica polysaccharides (SP). Water extraction and ethanol precipitation were used to isolate SP from S. parasitica leaf. S180, K562 and HL-60 cell lines proliferation inhibition by SP were detected by MTT assay. The expressions of Ki-67, Cyclin D1, Bax and Bcl-2 protein in the sarcoma S180 tissues were detected by immunohistochemistry technique to approach the anti-tumor mechanism of SP+ SP could not inhibit cancer cell proliferation. SP ip could inhibit the growth of sarcoma S180 in mice, 100 mg x kg(-1) x d(-1). SP ip was the optimal dose on inhibiting S180 growth, with the tumor inhibition rate of 54%. The expression of Ki-67, Cyclin D1, Bax and Bcl-2 protein in the sarcoma S180 tissues were detected by immunohistochemistry technique to approach the anti-tumor mechanism of SP. The result showed that SP could down-regulate the expression of Ki-67, CyclinD1 and Bcl-2 protein, and up-regulate the expression of Bax protein. It indicted that inhibiting cancer cell proliferation and promoting cancer cell apoptosis in vivo maybe one of the anti-cancer mechanisms of SP.

Download full-text PDF

Source
http://dx.doi.org/10.4268/cjcmm20100328DOI Listing

Publication Analysis

Top Keywords

sarcoma s180
16
bcl-2 protein
12
cancer cell
12
scurrula parasitica
8
s180 growth
8
ki-67 cyclin
8
cyclin bax
8
bax bcl-2
8
protein sarcoma
8
s180 tissues
8

Similar Publications

Article Synopsis
  • * Gd-Dex shows preferential accumulation in the marginal regions of S180 tumors shortly after injection, while the distribution in RIF-1 tumors is more uniform.
  • * The research highlights that the differences in drug distribution and pharmacokinetics between tumor types can influence the effectiveness of targeted nanomedicine delivery.
View Article and Find Full Text PDF

Lycorine (Lycoris radiata)-a unique natural medicine on breast cancer.

J Cell Mol Med

August 2024

Engineering Research Center for Medicine, Ministry of Education, Harbin University of Commerce, Harbin, China.

Breast cancer (BC) is one of the most common types of cancer among women worldwide. Lycorine (Lycoris radiata), a small molecule derived from the traditional Chinese herb Amaryllidaceae plants, has appeared potential effect on inhibiting the growth of cancer cells and inducing apoptosis in various types of cancer with minor side effects. To discuss the therapeutic effects and molecular mechanisms of lycorine on BC established by lycorine-treated S180 tumour-bearing mice in vivo.

View Article and Find Full Text PDF

Safer analgesic drugs remain a hard challenge because of cardiovascular and/or gastrointestinal toxicity, mainly. So, this study evaluated in vivo the antiproliferative actions of a fraction with casearins (FC) from leaves against human colorectal carcinomas and antihyperalgesic effects on inflammatory- or opiate-based pain relief and oncologic pain in Sarcoma 180 (S180)-bearing mice. Moreover, docking investigations evaluated the binding among Casearin X and NMDA(N-methyl-D-aspartate)-type glutamate receptors.

View Article and Find Full Text PDF

spore powder, valued for its nutritional and medicinal properties, contains polysaccharides crucial for its efficacy. However, the complex structural nature of these polysaccharides necessitates further investigation to fully realize their potential. This study aimed to investigate the effects of acid heat treatment on spore polysaccharides (GLSPs) to enhance their properties and application in antitumor activity.

View Article and Find Full Text PDF

Background: Immune escape remains a major challenge in the treatment of malignant tumors. Here, we studied the mechanisms underlying immune escape in the tumor microenvironment and identified a potential therapeutic target.

Methods: Pathological specimens from patients with liver cancer, soft tissue sarcoma, and liver metastasis of colon cancer were subjected to immunohistochemistry analysis to detect the expression of programmed death-1 (PD-1) in the tumor microenvironment (TME).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!